Gyurci John 4

What Happened
John Gyurci, Vice President and Chief Accounting Officer of MiniMed Group, Inc. (MMED), was granted 24,244 restricted stock units (RSUs) on July 1, 2026. The reported acquisition price is $0.00 (typical for RSU awards), so no cash was paid. The RSUs will convert into shares of common stock as they vest per the plan terms.

Key Details

• Transaction date and type: 2026-07-01 — Grant / Award of 24,244 RSUs at $0.00 (code A).
• Vesting: Footnote F1 — RSUs vest in approximately equal one‑third increments on the first, second and third anniversaries of the grant date.
• Shares after transaction: Not specified in the provided filing excerpt.
• Additional footnotes: F2 clarifies these are shares to be issued upon RSU vesting; F3 notes 375 shares were acquired under MMED’s 2026 Employee Stock Purchase Plan on June 30, 2026.
• Filing timeliness: Form 4 was filed on 2026-07-06 for a 2026-07-01 grant (filed five days later), which is outside the typical two-business-day reporting window and therefore appears late.

Context
RSU grants are compensation awards that vest over time and do not represent an open‑market purchase or sale by the insider at grant. They generally reflect company compensation policy rather than an immediate bullish or bearish trading signal. When these RSUs vest, they will be converted into shares (per F2) and any subsequent sale would be reported separately.